“It may be better at evading prior immunity, both from vaccination and infection.” — Aubree Gordon, PhD, MPH, of the University of Michigan in Ann Arbor, on the new BA.2.86 COVID variant.
“Children’s neurodevelopment is known to depend on several factors; however, until now doctors tended to consider just their life after birth.” — Francesca Crovetto, MD, PhD, of the Barcelona Center for Maternal and Fetal Medicine, discussing diet and lifestyle interventions throughout pregnancy.
“The message here is that multiple preventions are better than fewer.” — David Sullivan, MD, of Johns Hopkins University in Baltimore, discussing partial resistance to a mainstay therapeutic for malaria.
“This gives individuals information and therefore power to change the course of their life.” — Gill Livingston, MD, of University College London in England, on the value of dementia risk scores.
“It’s not a completely risk-free procedure.” — Raman Madan, MD, of Northwell Health in Huntington, New York, discussing “Barbie Botox.”
“It’s definitely an advance in our field.” — Stephen Pflugfelder, MD, of Baylor College of Medicine in Houston, discussing the first-ever corneal stem-cell transplants in the U.S.
“While the CDC is updating their language, they’re not actually updating their precautions in ways that they should based on the science.” — Jane Thomason, MSPH, CIH, an industrial hygienist for National Nurses United, discussing the CDC’s infection isolation precaution guidelines.
“That degree of ties is a little concerning, to say the least.” — Shamik Bhat, BS, of the Yale School of Medicine in New Haven, Connecticut, on the number of high-revenue patient advocacy organizations that have senior leaders with industry ties.
“It’s time to pivot, to evolve, to take the next step forward and redefine public health for this new era.” — Ashwin Vasan, MD, PhD, commissioner of the New York City Department of Health and Mental Hygiene, on getting public health back on track post-pandemic.
Please enable JavaScript to view the